Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.
3.

Regulation of hepatitis B virus gene expression.

Huan B, Siddiqui A.

J Hepatol. 1993;17 Suppl 3:S20-3. Review.

PMID:
8509635
4.

[Cres (cystatin-related epididymal spermatogenic) gene regulation and function].

Cornwall GA, Hsia N.

Zhonghua Nan Ke Xue. 2002;8(5):313-8. Review. Chinese.

PMID:
12479114
5.

Inhibition of albumin synthesis in chronic diseases: molecular mechanisms.

Chojkier M.

J Clin Gastroenterol. 2005 Apr;39(4 Suppl 2):S143-6. Review.

PMID:
15758650
6.

Liver enriched transcription factors and differentiation of hepatocellular carcinoma.

Hayashi Y, Wang W, Ninomiya T, Nagano H, Ohta K, Itoh H.

Mol Pathol. 1999 Feb;52(1):19-24. Review.

7.

Molecular mechanisms of hepatic apoptosis regulated by nuclear factors.

Wang K.

Cell Signal. 2015 Apr;27(4):729-38. doi: 10.1016/j.cellsig.2014.11.038. Review.

PMID:
25499978
8.

Flavin-containing monooxygenase 3 and human disease.

Motika MS, Zhang J, Cashman JR.

Expert Opin Drug Metab Toxicol. 2007 Dec;3(6):831-45. Review.

PMID:
18028028
9.

CCAAT/enhancer-binding proteins: structure, function and regulation.

Ramji DP, Foka P.

Biochem J. 2002 Aug 1;365(Pt 3):561-75. Review.

10.
11.

Epididymis-specific lipocalin promoters.

Suzuki K, Yu X, Chaurand P, Araki Y, Lareyre JJ, Caprioli RM, Orgebin-Crist MC, Matusik RJ.

Asian J Androl. 2007 Jul;9(4):515-21. Review.

12.

Transcriptional regulation and expression of CYP3A4 in hepatocytes.

Martínez-Jiménez CP, Jover R, Donato MT, Castell JV, Gómez-Lechón MJ.

Curr Drug Metab. 2007 Feb;8(2):185-94. Review.

PMID:
17305497
13.

Transcriptional Control of COX-2 via C/EBPbeta.

Wu KK, Liou JY, Cieslik K.

Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):679-85. Review.

14.

Beta2-glycoprotein I and its clinical significance: from gene sequence to protein levels.

Sodin-Semrl S, Rozman B.

Autoimmun Rev. 2007 Sep;6(8):547-52. Review.

PMID:
17854747
15.

Human flavin-containing monooxygenase: substrate specificity and role in drug metabolism.

Cashman JR.

Curr Drug Metab. 2000 Sep;1(2):181-91. Review.

PMID:
11465082
16.

The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms.

McCarver DG, Hines RN.

J Pharmacol Exp Ther. 2002 Feb;300(2):361-6. Review.

17.

Trimethylaminuria and a human FMO3 mutation database.

Hernandez D, Addou S, Lee D, Orengo C, Shephard EA, Phillips IR.

Hum Mutat. 2003 Sep;22(3):209-13. Review.

PMID:
12938085
18.
19.

Developmental and tissue-specific expression of human flavin-containing monooxygenases 1 and 3.

Hines RN.

Expert Opin Drug Metab Toxicol. 2006 Feb;2(1):41-9. Review.

PMID:
16863467
20.

The enhanceosome.

Panne D.

Curr Opin Struct Biol. 2008 Apr;18(2):236-42. doi: 10.1016/j.sbi.2007.12.002. Review.

PMID:
18206362
Items per page

Supplemental Content

Support Center